↓ Skip to main content

Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures

Overview of attention for article published in Cochrane database of systematic reviews, August 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

f1000
1 research highlight platform

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures
Published in
Cochrane database of systematic reviews, August 2013
DOI 10.1002/14651858.cd001769.pub2
Pubmed ID
Authors

Nolan SJ, Marson AG, Pulman J, Tudur Smith C

Abstract

This is an updated version of the previously published Cochrane review (Issue 4, 2009)Worldwide, phenytoin and valproate are commonly used antiepileptic drugs. It is generally believed that phenytoin is more effective for partial onset seizures, and that valproate is more effective for generalised onset tonic-clonic seizures with or without other generalised seizure types.

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 4%
United States 1 4%
Unknown 24 92%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 31%
Researcher 6 23%
Student > Ph. D. Student 6 23%
Student > Postgraduate 2 8%
Student > Bachelor 1 4%
Other 2 8%
Unknown 1 4%
Readers by discipline Count As %
Medicine and Dentistry 14 54%
Psychology 3 12%
Agricultural and Biological Sciences 2 8%
Environmental Science 1 4%
Business, Management and Accounting 1 4%
Other 3 12%
Unknown 2 8%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 October 2013.
All research outputs
#7,562,093
of 12,101,174 outputs
Outputs from Cochrane database of systematic reviews
#6,584
of 7,978 outputs
Outputs of similar age
#82,443
of 159,839 outputs
Outputs of similar age from Cochrane database of systematic reviews
#71
of 89 outputs
Altmetric has tracked 12,101,174 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,978 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one is in the 12th percentile – i.e., 12% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 159,839 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.